Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 6/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | ALPL | P05186 | 1/20 | 0.33 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
| ▸ | PDE5A | O76074 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27140068 | 0.89 | HTT (0.37) | HCAR2HTTALPLHCAR3GLA | |
| SCHEMBL27143064 | 0.88 | HCAR2 (0.40) | HCAR2HTTHCAR3GAA | |
| SCHEMBL27152639 | 0.85 | HCAR2 (0.39) | HCAR2HCAR3KCNH2 | |
| SCHEMBL27144214 | 0.84 | HCAR2 (0.44) | HCAR2HTTALPLHCAR3GAA | |
| SCHEMBL27139062 | 0.83 | HCAR2 (0.34) | HCAR2HTTALPLGLAKCNH2 | |
| SCHEMBL27154336 | 0.81 | CCNC (0.33) | HCAR2HTTALPL | |
| SCHEMBL27143712 | 0.80 | HCAR2 (0.40) | HCAR2HTTHCAR3GAA | |
| SCHEMBL27141935 | 0.78 | HCAR2 (0.45) | HCAR2HTTHCAR3GAA | |
| SCHEMBL27141710 | 0.77 | HTT (0.37) | HCAR2HTTALPLHCAR3GLA | |
| SCHEMBL27138813 | 0.76 | HCAR2 (0.44) | HCAR2HCAR3GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240208911-A1 | POLYMERIZATION INHIBITORS | BASF SE (DE) | 2024-06-27 | — | — | US | disclosed |
| EP-4326783-A1 | POLYMERIZATION INHIBITORS | BASF SE (DE) | 2024-02-28 | — | — | EP | disclosed |
| CN-117222675-A | polymerization inhibitor | 巴斯夫欧洲公司 | 2023-12-12 | — | — | CN | disclosed |
| WO-2022223336-A1 | POLYMERIZATION INHIBITORS | BASF SE (DE) | 2022-10-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240208911-A1 | POLYMERIZATION INHIBITORS | CDK5, CABLES1, DPYD | HCAR2 2930/4885HTT 1252/4885ALPL 4430/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.